A novel treatment for height growth in patients with growth hormone insensitivity syndrome by cyproheptadine hydrochloride
Clinical Endocrinology Mar 15, 2018
Razzaghy-Azar M, et al. - Researchers resolved to examine the impact of cyproheptadine hydrochloride (CyproH) on the growth parameters of subjects with growth hormone insensitivity syndrome (GHIS). In the study cohort, CyproH resulted in height growth. Hence, it could serve as an alternative option to IGF-I injection.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
